Fluarix quadrivalent flu vaccine FY 2018-19. This vaccine is required for all soldiers in the ndarng. The VA has an established contract with VA and this was used per direction of US army medical…

Ended Awarded Last action

Contract number
W901UZ18F0058
Awardee
Awarding agency
Obligated
$38,340

Award facts

Contract value 100% obligated
$38,340.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Fixed Price Award Fee
Place of performance
Durham, NC 27709, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · 3,000 doses of fluarix quadrivalent flu vaccine 2018-19 $0
Original award $38,340

Description

Fluarix quadrivalent flu vaccine FY 2018-19. This vaccine is required for all soldiers in the ndarng. The VA has an established contract with VA and this was used per direction of US army medical command.

Quick answers

Who was awarded contract W901UZ18F0058?

W901UZ18F0058 was awarded to Glaxosmithkline, LLC by North Dakota National Guard (Army National Guard) on July 13, 2018.

How much is contract W901UZ18F0058 worth?

The government has obligated $38,340 on W901UZ18F0058.

Is contract W901UZ18F0058 an order under another contract?

Yes. W901UZ18F0058 is a delivery order under V797P2298D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract W901UZ18F0058 competed?

The extent of competition for W901UZ18F0058 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award